32 phenotypes from 1 allele in 1 genetic background

Allelic Composition Genetic Background	Annotated Term	Reference
Osmrtm1Mtan/Osmrtm1Mtan B6.129S-Osmrtm1Mtan	abnormal common myeloid progenitor cell morphology	J:86261
	abnormal definitive hematopoiesis	J:86261
	abnormal erythroid progenitor cell morphology	J:86261
	abnormal megakaryocyte progenitor cell morphology	J:86261
	anemia	J:86261
	decreased erythrocyte cell number	J:86261
	decreased hematocrit	J:86261
	decreased liver glycogen level	J:214124
	decreased megakaryocyte cell number	J:86261
	normal hematopoietic system phenotype	J:86261
	hepatic steatosis	J:214124
	impaired glucose tolerance	J:214124
	increased circulating cholesterol level	J:214124
	increased circulating free fatty acids level	J:214124
	increased circulating glucose level	J:214124
	increased circulating insulin level	J:214124
	increased circulating interleukin-10 level	J:214124
	increased circulating leptin level	J:214124
	increased circulating triglyceride level	J:214124
	increased circulating tumor necrosis factor level	J:214124
	increased epididymal fat pad weight	J:214124
	increased food intake	J:214124
	increased inflammatory response	J:214124
	increased liver cholesterol level	J:214124
	increased liver triglyceride level	J:214124
	increased liver weight	J:214124
	increased pancreatic beta cell number	J:214124
	increased subcutaneous adipose tissue amount	J:214124
	increased susceptibility to diet-induced obesity	J:214124
	insulin resistance	J:214124
	thrombocytopenia	J:86261
	white adipose tissue inflammation	J:214124